30172984|t|Homocysteine-lowering gene therapy rescues signaling pathways in brain of mice with intermediate hyperhomocysteinemia.
30172984|a|Hyperhomocysteinemia due to cystathionine beta synthase (CBS) deficiency is associated with diverse cognitive dysfunction. Considering the role of the serine/threonine kinase DYRK1A, not only in developmental defects with life-long structural and functional consequences, but also in multiple neurodegenerative diseases, its protein expression and kinase activity has been analyzed in brain of heterozygous CBS deficient mice and found to be increased. We previously demonstrated that specific liver treatment with an adenovirus expressing Dyrk1A normalizes hepatic DYRK1A level and decreases hyperhomocysteinemia in mice with moderate to intermediate hyperhomocysteinemia. We here use a hepatocyte-specific recombinant adeno-associated viral (AAV) serotype 8-mediated DYRK1A gene therapy (AAV2/8-DYRK1A) to analyze the effect of hepatic Dyrk1A gene transfer on some altered molecular mechanisms in brain of mice with intermediate hyperhomocysteinemia. Our selective hepatic treatment alleviates altered DYRK1A protein level and signaling pathways in brain of mice, the MAPK/ERK and PI3K/Akt pathways initiated by receptor tyrosine kinase, the BDNF dependent TrkB pathway, and NFkB pathway. These results demonstrate the positive effect of AAV2/8-DYRK1A gene transfer on neuropathological and inflammatory processes in brain of mice with intermediate hyperhomocysteinemia.
30172984	0	12	Homocysteine	Chemical	MESH:D006710
30172984	74	78	mice	Species	10090
30172984	97	117	hyperhomocysteinemia	Disease	MESH:D020138
30172984	119	139	Hyperhomocysteinemia	Disease	MESH:D020138
30172984	147	191	cystathionine beta synthase (CBS) deficiency	Disease	MESH:D006712
30172984	219	240	cognitive dysfunction	Disease	MESH:D003072
30172984	294	300	DYRK1A	Gene	13548
30172984	314	335	developmental defects	Disease	MESH:D000094602
30172984	412	438	neurodegenerative diseases	Disease	MESH:D019636
30172984	540	544	mice	Species	10090
30172984	659	665	Dyrk1A	Gene	1859
30172984	685	691	DYRK1A	Gene	13548
30172984	712	732	hyperhomocysteinemia	Disease	MESH:D020138
30172984	736	740	mice	Species	10090
30172984	771	791	hyperhomocysteinemia	Disease	MESH:D020138
30172984	839	861	adeno-associated viral	Species	
30172984	863	866	AAV	Species	
30172984	888	894	DYRK1A	Gene	1859
30172984	909	913	AAV2	Species	10804
30172984	916	922	DYRK1A	Gene	13548
30172984	957	963	Dyrk1A	Gene	1859
30172984	1027	1031	mice	Species	10090
30172984	1050	1070	hyperhomocysteinemia	Disease	MESH:D020138
30172984	1123	1129	DYRK1A	Gene	13548
30172984	1179	1183	mice	Species	10090
30172984	1194	1197	ERK	Gene	26413
30172984	1207	1210	Akt	Gene	11651
30172984	1233	1257	receptor tyrosine kinase	Gene	22174
30172984	1263	1267	BDNF	Gene	12064
30172984	1278	1282	TrkB	Gene	18212
30172984	1359	1363	AAV2	Species	10804
30172984	1366	1372	DYRK1A	Gene	1859
30172984	1412	1424	inflammatory	Disease	MESH:D007249
30172984	1447	1451	mice	Species	10090
30172984	1470	1490	hyperhomocysteinemia	Disease	MESH:D020138
30172984	Association	MESH:D020138	1859
30172984	Association	MESH:D000094602	13548
30172984	Association	MESH:D006710	MESH:D020138
30172984	Association	MESH:D007249	1859
30172984	Positive_Correlation	13548	1859
30172984	Association	12064	18212
30172984	Association	MESH:D020138	13548
30172984	Association	MESH:D019636	13548

